Position in ELAN
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$3,331,997
-$78,530 QoQ
Shares Held
135,392
-5.0% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.47%
of 13F equity value
Holder Rank
#151
of 515 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 16%
Shared 0%
None 84%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Phocas Financial Corp. holds $23,724,903 across 4 Drug Manufacturers - Specialty & Generic names. ELAN ranks #3 (14.0% of the industry book) .
All Filings in ELAN
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,331,997 | 135,392 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $3,410,527 | 142,521 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $4,135,745 | 182,755 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $4,429,974 | 219,959 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,076,454 | 215,438 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $2,261,763 | 215,406 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $2,756,526 | 227,624 | Shares | Sole | 2025-03-05 | |
| 2024-09-30 | $3,372,104 | 229,551 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $5,975,535 | 414,105 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $6,869,085 | 421,934 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $3,857,148 | 258,869 | Shares | Sole | 2024-01-30 | |
| No filing history on record for this holder in this stock. | ||||||